BioSpace News Archive

Reproductive Genetics Market Trend – Increasing Awareness About Genetic Testing and Screening

Rapid advancements in genomic technology, increasing number of IVF procedures, and rising funds by public and private organizations to support diagnosis of genetic disorders are some key factors expected to drive global Reproductive Genetics market growth.

April 26, 2022
·
6 min read
Autologous Fat Grafting Market Opportunity Assessment and Forecast up to 2027

Albany NY, United States: Autologous fat grafting will continue to gain popularity as a potentially non-invasive procedure in reconstructive and aesthetic surgeries.

April 26, 2022
·
5 min read
Home Healthcare Market is expected to Reach Valuation of US$ 499.6 Bn by 2028, Says TMR

Albany NY, United States: According to the report, the global home healthcare market was valued at US$ 238.1 Bn in 2020 and is projected to expand at a CAGR of 10.5% from 2021 to 2028.

April 26, 2022
·
5 min read
Generic Injectables Market to Touch US$ 307.7 Bn by 2031, Increase in Generic Population to Drive the Market

Albany NY, United States: During the peak of the coronavirus outbreak amid the second wave in India, there had been an unprecedented demand for Remdesivir - an antiviral medication for the treatment of patients.

April 26, 2022
·
6 min read
Short Bowel Syndrome Market to Cross Valuation of US$ 3.66 Bn by 2031, Glucagon-like Peptide-2 (GLP-2) to Dominate the Market

Albany NY, United States: According to the report, the global short bowel syndrome market was valued at US$ 728.3 Mn in 2020 and is projected to expand at a CAGR of 15.9% from 2021 to 2031.

April 26, 2022
·
4 min read
Business

Midatech Pharma PLC Announces Results for the Year Ended 31 December 2021

Midatech Pharma PLC announces its audited preliminary results for the year ended 31 December 2021.

April 26, 2022
·
5 min read
Business

ViGeneron announces follow-on collaboration with Daiichi Sankyo to develop a novel gene therapy for prevalent eye diseases

ViGeneron GmbH announced a follow-on collaboration with Daiichi Sankyo Company, Limited to utilize ViGeneron’s novel engineered recombinant adeno-associated virus vectors to address an undisclosed target for the treatment of prevalent eye diseases.

April 26, 2022
·
2 min read
Business

Reviva Pharmaceuticals to Host Key Opinion Leader Webinar on Brilaroxazine for Schizophrenia and Other Neuropsychiatric Disorders

Reviva Pharmaceuticals Holdings, Inc. announced that it will host a key opinion leader webinar on brilaroxazine for schizophrenia and other neuropsychiatric disorders on Tuesday, May 3, 2022 at 10:00am Eastern Time.

April 26, 2022
·
8 min read
Biotech Beach

Axonics® to Participate in BofA Securities 2022 Healthcare Conference

Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, will participate in the BofA Securities 2022 Healthcare Conference on May 10, 2022.

April 26, 2022
·
1 min read
Genetown

Apertura Gene Therapy Launches with $67M Series A Financing from Deerfield and an Innovative Technology Platform to Develop Genetic Medicines

Apertura Gene Therapy announced that it has launched with a Series A financing of up to $67M from Deerfield Management Company to develop genetic medicines using platform technologies that address key limitations of genetic medicine delivery and expression.

April 26, 2022
·
5 min read